Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Next shareholder meeting - January 28, 2010

Hah!!!!

Better accommodate shareholders by holding it in JAN in CHICAGO..... I guess it could have been harder if the meeting was held in the arctic circle!!!

The move to the Chicago location was undertaken to better accommodate shareholder access from various locations across the country

Share
New Message
Please login to post a reply